Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dow Corning makes breast implant settlement offer:

This article was originally published in Clinica

Executive Summary

Women with silicone breast implant claims have 60 days to decide whether or not to accept Dow Corning's proposed $3.2 billion settlement, details of which they have received in the post. The proposed plan, which was approved last November by the company and a committee representing the claimants, could result in women receiving between $2,000 and $250,000, or choosing to litigate their claims (see Clinica No 834, p 12). The plan is also designed to resolve Dow Corning's chapter 11 bankruptcy.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT077798

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel